Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent. The company was founded by Jonathan Kaufman and Michael Chancellor on February 15, 2005 and is headquartered in Pittsburgh, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
7
Frequently Asked Questions
What is Market Cap of Lipella Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Lipella Pharmaceuticals Inc market cap is $2.77M.
What is the 52-week high for Lipella Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Lipella Pharmaceuticals Inc 52 week high is $7.31 as of September 18, 2025.
What is the 52-week low for Lipella Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Lipella Pharmaceuticals Inc 52 week low is $0.55 as of September 18, 2025.
What is Lipella Pharmaceuticals Inc stock price today?
Lipella Pharmaceuticals Inc stock price today is $0.64.
What was Lipella Pharmaceuticals Inc stock price yesterday?
Lipella Pharmaceuticals Inc stock price yesterday was $0.60.
What is the PE ratio of Lipella Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Lipella Pharmaceuticals Inc’s P/E ratio is -0.18.
What is the Price-to-Book ratio of Lipella Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Lipella Pharmaceuticals Inc P/B ratio is 0.9777.
What is the 50-day moving average of Lipella Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Lipella Pharmaceuticals Inc 50-day moving average is $0.6539.
How many employess does Lipella Pharmaceuticals Inc has?